Chemical Proteomic Profiling of the Histaminylation Proteome in Cancer Cells Unveils Uncharted Epigenetic Marks on Core Histones

This study introduces a novel Nτ-propargylated histamine probe to overcome the limitations of existing antibodies, enabling the first chemical proteomic profiling of the histaminylation proteome in cancer cells and the discovery of previously uncharacterized TGM2-catalyzed epigenetic marks on core histones.

The Gist

Imagine your body is a bustling city, and histamine is a famous, busy messenger. For a long time, scientists knew this messenger only delivered notes by knocking on doors (binding to receptors) to tell cells to react—like sneezing during an allergy or making stomach acid.

But recently, researchers discovered a secret, more permanent way this messenger works: instead of just knocking on the door, it can glue itself directly onto the city's most important blueprints (proteins). This process is called histaminylation.

Here is the story of how this team of scientists at Purdue University cracked the code on this "gluing" process, specifically looking at how it affects cancer cells.

1. The Problem: The Invisible Glue

The scientists knew this "gluing" happened, but they couldn't see it. It's like trying to find a specific type of invisible ink on a document. They didn't have a special flashlight (an antibody) that could light up these glued-on histamine molecules. Without this tool, they couldn't map out where this gluing happens or what it does.

2. The Solution: A "Spy" Probe

To solve this, the team invented a chemical spy.

• They took the histamine molecule and attached a tiny, invisible "handle" to it (a propargyl group). Think of this like attaching a magnetic tag to a key.
• They made sure this tag didn't change how the key worked. The cell's "glue gun" enzyme (called TGM2) still recognized the key and glued it onto the target proteins just like normal histamine.
• They also made a fake key (a negative control) that looked the same but didn't have the handle, to prove their results were real.

3. The Investigation: Catching the Glue in Action

They sent this "spy key" into cancer cells (specifically colorectal and stomach cancer cells).

• The Setup: The cells' natural "glue guns" (TGM2) grabbed the spy key and glued it onto various proteins inside the cell.
• The Reveal: Because the spy key had that magnetic handle, the scientists could later use a special "magnet" (a chemical reaction called Click Chemistry) to pull all the glued proteins out of the soup.
• The Map: Once they had the proteins, they used a high-tech microscope (Mass Spectrometry) to read the labels. They found over 400 proteins that had been glued to histamine.

4. The Big Discovery: The "Master Switches"

The most exciting part of the discovery was finding that the "glue" wasn't just stuck on random junk; it was stuck on the Core Histones.

• What are Histones? Imagine DNA as a very long, tangled string of yarn. To keep it from getting messy, the cell wraps it around spools called histones. These spools are the "master switches" that decide which genes are turned on or off (epigenetics).
• The New Marks: Before this study, scientists only knew of one place on these spools where histamine could glue itself (on Histone H3).
• The Breakthrough: This team found seven brand new spots where histamine glues itself onto the spools (on Histones H2A, H2B, H4, and H2AX).

Why Does This Matter?

Think of these new spots as new buttons on a remote control for the cell's DNA.

• When histamine glues itself to these new buttons, it might change how the cell reads its genetic instructions.
• Since this happens in cancer cells, these new "buttons" might be helping the cancer grow or survive.
• The scientists also noticed that the "glue" on these spools might be fighting against other chemical marks (like methylation), acting like a tug-of-war that changes the cell's behavior.

The Takeaway

This paper is like finding a hidden layer of a video game. For years, we thought histamine only knocked on the front door. Now, we know it also has a secret backdoor where it can permanently modify the game's code (the DNA spools).

By building a special "spy tool," the researchers mapped out this hidden world for the first time. This opens up a whole new frontier for understanding how cancer works and could lead to new drugs that stop the "glue gun" from messing with the cell's master switches.

Technical Summary

1. Problem Statement

• Biological Context: Histamine is a well-known signaling molecule involved in immune defense, allergy, and cancer. While its noncovalent interactions with G-protein coupled receptors (H1–H4) are well-characterized, a covalent mechanism called histaminylation has recently emerged.
• The Gap: Histaminylation is a post-translational modification (PTM) where an isopeptide bond forms between the primary amine of histamine and the $\gamma$-carboxyl group of a glutamine residue. This reaction is catalyzed by Transglutaminase 2 (TGM2).
• The Challenge: Despite the discovery of histamine modification on Histone H3 (H3Q5), the global histaminylation proteome remains largely unexplored. The primary bottleneck is the lack of efficient molecular tools, specifically the absence of pan-specific antibodies capable of recognizing histaminylated glutamine residues. Consequently, the full scope of TGM2-mediated targets and their epigenetic implications in cancer cells are unknown.

2. Methodology

The authors employed a chemical proteomics approach centered on the design and application of a novel activity-based probe.

• Probe Design (N$\tau$-PH):
  • The team synthesized N$\tau$-propargylated histamine (N$\tau$-PH), a histamine analog containing a propargyl (alkyne) "click" handle attached to the N$\tau$ position of the imidazole ring.
  • Rationale: The N$\tau$ position was chosen because it does not interfere with the transamidation reaction catalyzed by TGM2.
  • Control: A negative control, N$\alpha$-PH, was synthesized. It has the same molecular weight but the propargyl group is on the N$\alpha$ position, rendering it unable to undergo TGM2-mediated transamidation.
• In Vitro Validation:
  • Reactivity was tested using MALDI-TOF MS and LC-MS on histone H3 peptides and full-length H3 proteins.
  • Results confirmed that N$\tau$-PH acts as a monoaminylation donor comparable to native histamine, while N$\alpha$-PH showed no reactivity.
• Chemical Proteomics Workflow:
  • Cell Lines: Colorectal cancer (HCT 116) and stomach cancer (AGS) cells were used due to their high endogenous TGM2 expression.
  • Labeling: Cells were treated with N$\tau$-PH. Endogenous TGM2 incorporated the probe into target proteins.
  • Enrichment: A Copper(I)-catalyzed Azide-Alkyne Cycloaddition (CuAAC) was performed to conjugate an azide-tagged biotin (or a cleavable biotin linker) to the probe-labeled proteins.
  • Analysis: Proteins were enriched, digested, and analyzed via high-resolution LC-MS (Sciex ZenoTOF 7600) to identify modification sites.
• Verification:
  • Identified sites were validated using in vitro enzymatic assays with recombinant TGM2 and synthetic peptides or full-length histones.
  • Confocal microscopy was used to visualize subcellular localization.

3. Key Contributions

• Development of N$\tau$-PH Probe: The creation of the first effective chemical biology tool for capturing and profiling the histaminylation proteome, overcoming the limitation of lacking specific antibodies.
• Global Profiling: The first comprehensive mapping of the histaminylation proteome in cancer cells, identifying hundreds of modified proteins.
• Discovery of Novel Epigenetic Marks: The identification of seven previously unknown histaminylation sites on core histones (H2AX, H2A, H2B, and H4), expanding the known landscape of histone PTMs beyond the previously known H3Q5.

4. Key Results

• Proteome Scale:
  • In HCT 116 cells, 455 proteins were identified as histaminylated.
  • In AGS cells, >200 proteins were identified.
  • 104 proteins were common to both cell lines.
• Functional Enrichment: Bioinformatics analysis revealed that nucleoproteins (involved in transcription and chromatin regulation) constitute a significant portion of the histaminylation proteome. Confocal microscopy confirmed the nuclear localization of these modified proteins.
• Substrate Specificity: pLogo analysis indicated that while TGM2 is promiscuous, it exhibits preferred substrate sequence motifs.
• Novel Histone Marks:
  • H2AX: Five sites were identified: Q24, Q84, Q104, Q122, and Q137. Notably, Q84 and Q104 are in the globular domain and C-terminal tail, respectively.
  • Canonical H2A: Four sites identified (Q24, Q84, Q104, Q122), sharing conservation with H2AX.
  • H2B: One new site identified at Q47.
  • H4: One new site identified at Q27.
  • Verification: These sites were confirmed via LC-MS analysis of recombinant nucleosome core particles (NCPs) treated with TGM2 and N$\tau$-PH.
• Comparison with Other Monoaminylations: The study highlights that while H3Q5 can be modified by serotonylation, dopaminylation, or histaminylation, the resulting biophysical properties (charge, steric hindrance) differ. For instance, H3Q5his (positive charge) inhibits binding to WDR5, antagonizing H3K4 methylation, whereas H3Q5ser enhances it. The new histone marks likely possess similar distinct regulatory functions.

5. Significance

• Mechanistic Insight: This work establishes that histamine acts as a direct covalent regulator of chromatin structure through TGM2, adding a new layer to the "histone code."
• Cancer Relevance: By identifying histaminylation on core histones in cancer cells, the study suggests a potential mechanism for how histamine signaling influences gene transcription and DNA repair (e.g., potential crosstalk between H2AXQ137 histaminylation and $\gamma$H2AX phosphorylation in DNA double-strand break repair).
• Therapeutic Potential: The identification of these specific PTM sites and the validation of TGM2 as the installing enzyme open new avenues for cancer therapeutics. Targeting TGM2-mediated monoaminylations could offer novel strategies to modulate epigenetic states in cancer.
• Methodological Advance: The N$\tau$-PH probe serves as a versatile tool for future studies to map the dynamics of histaminylation in various physiological and pathological contexts.

In summary, this paper bridges a critical gap in chemical biology by providing the first global view of the histaminylation proteome, revealing that TGM2-mediated histamine modification is a widespread epigenetic mechanism with significant implications for cancer biology.